Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.24 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1661
    +0.0009 (+0.08%)
     

  • GBP/USD

    1.2565
    +0.0018 (+0.14%)
     

  • Bitcoin GBP

    50,519.04
    -131.87 (-0.26%)
     

  • CMC Crypto 200

    1,364.74
    +52.11 (+3.97%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • CRUDE OIL

    78.68
    +0.57 (+0.73%)
     

  • GOLD FUTURES

    2,332.90
    +24.30 (+1.05%)
     

  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     

  • HANG SENG

    18,578.30
    +102.38 (+0.55%)
     

  • DAX

    18,175.21
    +173.61 (+0.96%)
     

  • CAC 40

    7,996.64
    +39.07 (+0.49%)
     

GSK says China bribery charges "deeply concerning"

Reuters - UK Focus

LONDON, May 14 (Reuters) - British drugmaker GlaxoSmithKline (Frankfurt: GS7.F - news) , whose former China head and other colleagues have been charged with corruption by Chinese police, said on Wednesday the case was deeply concerning.

Britain's biggest pharmaceuticals group said it understood the authorities had issued the case to the Changsha People's Procurator in Hunan Province and the procurator was now reviewing the case.

"We take the allegations that have been raised very seriously. They are deeply concerning to us and contrary to the values of GSK," it said in a brief statement.

"We want to reach a resolution that will enable the company to continue to make an important contribution to the health and welfare of China and its citizens." (Reporting by Ben Hirschler; editing by Kate Holton)